International Patent: ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING

GENEVA, Nov. 6 -- TEMPUS AI, INC. filed a patent application (US2026/026176) for “ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING”. With publication no. WO/2026/232011, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16B 20/20

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....